by GOAI

由GOAI生成

Share To

分享到

Researchers have identified a potential dietary intervention that may impact obesity treatment by altering gut microbiota and metabolic pathways. A study published in *Nature Communications* reveals that a lysine-restricted diet significantly reduces obesity. The research team, led by Zhao, F., Zou, Z., Liu, Z., and others, examined the effects of limiting lysine intake on weight management and metabolic health.

研究人员发现了一种可能通过改变肠道微生物群和代谢途径来影响肥胖治疗的潜在饮食干预方法。发表在《自然通讯》上的一项研究表明，限制赖氨酸的饮食可以显著减轻肥胖。由赵峰、邹志伟、刘智等人领导的研究团队探讨了限制赖氨酸摄入对体重管理和代谢健康的影响。

Their findings suggest that dietary lysine restriction influences gut microbial composition and associated metabolic processes..

他们的研究结果表明，饮食中赖氨酸的限制会影响肠道微生物的组成和相关的代谢过程。

The study highlights how changes in lysine levels affect key interactions between the gut microbiome and host metabolism. Researchers observed notable improvements in obesity-related markers among subjects following the lysine-restricted diet. The investigation focused on understanding how specific dietary modifications can regulate microbial activity within the gastrointestinal system to influence overall health outcomes.

该研究强调了赖氨酸水平的变化如何影响肠道微生物组与宿主代谢之间的关键相互作用。研究人员观察到，在遵循赖氨酸限制饮食的受试者中，与肥胖相关的指标有显著改善。该研究的重点是了解特定饮食调整如何调节胃肠道内的微生物活动，从而影响整体健康结果。

These results provide insight into the role of amino acid intake in shaping metabolic responses through gut microbe modulation..

这些结果揭示了氨基酸摄入通过肠道微生物调节来影响代谢反应的作用。

Newsflash | Powered by GeneOnline AI

新闻快讯 | 由GeneOnline AI提供支持

Source: GO-AI-ne1

来源：GO-AI-ne1

For any suggestion and feedback, please contact us.

如果有任何建议和反馈，请联系我们。

Date: November 12, 2025

日期：2025年11月12日

Related posts:

相关文章：

CDMO Pricing Shifts: Value-Based Models Replacing Cost-Plus in Pharma Partnerships

CDMO定价转变：制药合作中基于价值的模式正在取代成本加成模式

Researchers Explore CAR-T Cell Therapies to Overcome Challenges in Treating Solid Tumors

研究人员探索CAR-T细胞疗法以克服治疗实体瘤的挑战

Revumenib Shows Potential in Treating NPM1-Mutant Acute Myeloid Leukemia Beyond KMT2A-Rearranged Cases

Revumenib在治疗NPM1突变型急性髓系白血病方面显示出潜力，不仅限于KMT2A重排病例。

FLAURA2 Trial Shows Improved Survival in EGFR-Mutant NSCLC with Osimertinib and Platinum–Pemetrexed Combination Therapy

FLAURA2试验显示，奥希替尼联合铂-培美曲塞治疗EGFR突变型非小细胞肺癌可改善生存率

©www.geneonline.com All rights reserved. Collaborate with us:

©www.geneonline.com 保留所有权利。与我们合作：

[email protected]

电子邮件地址

Author

作者

GOAI

GOAI

Related Post

相关文章

News Flash

新闻快讯

Enzymes Expand Applications from Food Industry to Biofuel Production and Wastewater Treatment

酶的应用从食品工业扩展到生物燃料生产和废水处理

2025-11-12

2025年11月12日